CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 88 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2017. The put-call ratio across all filers is 18.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | -42.2% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 173 | +73.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 100 | -80.0% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | -25.0% | 500 | -16.7% | 0.00% | -50.0% |
| Q1 2018 | $4,000 | 0.0% | 600 | +20.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $4,000 | 0.0% | 500 | -16.7% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,563,925 | $16,717,000 | 29.31% |
| Cormorant Asset Management, LP | 2,000,000 | $13,580,000 | 1.50% |
| Perceptive Advisors | 2,701,023 | $18,339,000 | 1.18% |
| Fosun International Ltd | 700,071 | $4,753,000 | 0.53% |
| Ghost Tree Capital, LLC | 200,000 | $1,358,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 81,302 | $552,000 | 0.21% |
| IFP Advisors, Inc | 300,000 | $2,037,000 | 0.11% |
| CONNING INC. | 351,280 | $2,385,000 | 0.10% |
| WOODSTOCK CORP | 39,931 | $271,000 | 0.06% |
| Yellowstone Partners, LLC | 15,944 | $108,000 | 0.04% |